JPMORGAN CHASE & CO - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$445,616
+6265.9%
201,636
+7250.9%
0.00%
Q1 2023$7,000
+233233.3%
2,743
+67.7%
0.00%
Q4 2022$3
-100.0%
1,636
-58.7%
0.00%
Q3 2022$10,000
+150.0%
3,958
+91.9%
0.00%
Q2 2022$4,000
-95.3%
2,063
-92.9%
0.00%
Q1 2022$86,000
-14.9%
28,946
+28.9%
0.00%
Q4 2021$101,000
-1.9%
22,449
+5.2%
0.00%
Q3 2021$103,000
-24.3%
21,337
+7.5%
0.00%
Q2 2021$136,000
+18.3%
19,857
+21.1%
0.00%
Q1 2021$115,000
-5.0%
16,403
-15.1%
0.00%
Q4 2020$121,000
+36.0%
19,310
+18.8%
0.00%
Q3 2020$89,000
+23.6%
16,258
+18.5%
0.00%
Q2 2020$72,000
+118.2%
13,715
+30.6%
0.00%
Q1 2020$33,000
-99.5%
10,501
-99.3%
0.00%
-100.0%
Q4 2019$6,171,000
+389.0%
1,531,181
+424.3%
0.00%
Q3 2019$1,262,000
+17.0%
292,048
+4.2%
0.00%
Q2 2019$1,079,000
-32.6%
280,228
-6.2%
0.00%
Q1 2019$1,602,000
-1.8%
298,814
-6.0%
0.00%
Q4 2018$1,631,000
-50.1%
317,946
-5.7%
0.00%
-100.0%
Q3 2018$3,271,000
+1.3%
337,110
+6.5%
0.00%0.0%
Q2 2018$3,229,000
+9.3%
316,634
+39.4%
0.00%0.0%
Q1 2018$2,953,000
-33.6%
227,164
-8.5%
0.00%0.0%
Q4 2017$4,446,000
+9.8%
248,377
+54.5%
0.00%0.0%
Q3 2017$4,051,000
-15.8%
160,781
-19.5%
0.00%0.0%
Q2 2017$4,813,000
+2406.8%
199,725
+1898.2%
0.00%
Q1 2017$192,000
-44.0%
9,995
-55.2%
0.00%
Q4 2016$343,000
-89.6%
22,301
-89.7%
0.00%
-100.0%
Q1 2016$3,290,000
-20.0%
216,9020.0%0.00%0.0%
Q4 2015$4,115,000
-0.2%
216,902
-0.1%
0.00%0.0%
Q3 2015$4,123,000
-26.2%
217,017
+0.1%
0.00%0.0%
Q2 2015$5,590,000
-17.6%
216,902
-0.1%
0.00%
-50.0%
Q1 2015$6,787,000217,1360.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders